Seana Carson - Sep 5, 2023 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
EVP, General Counsel
Signature
/s/ Brianna M. Cetrulo, attorney-in-fact
Stock symbol
BHC
Transactions as of
Sep 5, 2023
Transactions value $
-$484,016
Form type
4
Date filed
9/6/2023, 04:33 PM
Previous filing
Mar 7, 2023
Next filing
Nov 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Tax liability -$429K -51.3K -11.58% $8.35 392K Sep 5, 2023 Direct F1
transaction BHC Common Shares, No Par Value Sale -$55.4K -6.69K -1.71% $8.28 385K Sep 6, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F2 Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.